However, the promoter at the 5’ end of the GLI1 gene is replaced by the highly active promoter of the fusion partner, which results in elevated expression of GLI1 and subsequent activation of downstream gene transcription, thereby promoting tumor development (22, 23). The gene discussed is GLI1; the disease is neoplasm.